Browse Data and Analysis

On December 23, the Ministry of Health, Labour, and Welfare (MHLW) amended the handling procedures for products that are derived from the crossbreeding of genome edited varieties which have already...

There have been no recent significant official changes to the genetically engineered (GE) policies established by the New Zealand government.

On December 11, Japan’s Ministry of Health, Labour, and Welfare (MHLW) and Ministry of Agriculture, Forestry, and Fisheries (MAFF) announced their determination that a genome edited tomato...

In 2020, China committed to a number of reforms to its agricultural biotechnology policies under the U.S.-China Economic and Trade Agreement (“Phase One Agreement”).

Korea is in the process of drafting a proposal to revise its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.

Since the previous report, Taiwan has granted approval for imports of genetically engineered (GE) products for processing, food, and feed use.

The Australian federal government is supportive of biotechnology and has committed considerable longterm funding to research and development.

As of October 2020, Vietnam has issued 45 Certificates of Food/Feed Approval for genetically engineered (GE) products for corn, soybeans, canola, sugar beets, alfalfa, and cotton.

The Australian federal government is supportive of biotechnology and has committed considerable longterm funding to research and development.

The Australian federal government is supportive of biotechnology and has committed considerable long-term funding to research and development. The Australian Productivity Commission recently completed an inquiry into the regulatory burden on farm businesses focusing on regulations that have a material impact on the competitiveness and productivity of Australian agriculture, including the impact of regulations for genetically engineered (GE) products.

This report updates the 2019 Agricultural Biotechnology Annual Report.

Singapore does not have any domestic commercial production of plant biotechnology.